Retinal Functional Impairment in Diabetic Retinopathy

Background: Diabetic retinopathy (DR) is a neurodegenerative disease of the retina. The aim of our study was to analyze latency changes in a full-field electroretinogram (ERG) in patients with type 2 diabetes. Material: This prospective study included 15 diabetic patients without DR, 16 diabetic pat...

Full description

Bibliographic Details
Main Authors: Cornelia Andreea Tănasie, Alexandra Oltea Dan, Oana Maria Ică, Maria Filoftea Mercuț, George Mitroi, Citto-Iulian Taisescu, Veronica Sfredel, Ramona Ingrid Corbeanu, Carmen Luminița Mocanu, Ciprian Danielescu
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/12/1/44
_version_ 1797340062391730176
author Cornelia Andreea Tănasie
Alexandra Oltea Dan
Oana Maria Ică
Maria Filoftea Mercuț
George Mitroi
Citto-Iulian Taisescu
Veronica Sfredel
Ramona Ingrid Corbeanu
Carmen Luminița Mocanu
Ciprian Danielescu
author_facet Cornelia Andreea Tănasie
Alexandra Oltea Dan
Oana Maria Ică
Maria Filoftea Mercuț
George Mitroi
Citto-Iulian Taisescu
Veronica Sfredel
Ramona Ingrid Corbeanu
Carmen Luminița Mocanu
Ciprian Danielescu
author_sort Cornelia Andreea Tănasie
collection DOAJ
description Background: Diabetic retinopathy (DR) is a neurodegenerative disease of the retina. The aim of our study was to analyze latency changes in a full-field electroretinogram (ERG) in patients with type 2 diabetes. Material: This prospective study included 15 diabetic patients without DR, 16 diabetic patients with non-proliferative DR, 14 patients with pre-proliferative DR, 15 patients with proliferative DR, and 14 age-matched controls. All the participants underwent ophthalmologic examination and full-field ERGs. The ERGs were recorded with the Metrovision MonPackOne system. The latencies were analyzed for “a”- and “b”-waves in the dark-adapted (DA) 0.01 ERG, DA 3.0 ERG, DA oscillatory potentials, light-adapted (LA) 3.0 ERG, and 30 Hz flicker ERG. Results: The delayed responses of healthy subjects compared to diabetic patients without DR were the DA oscillatory potentials (25.45 ± 1.04 ms vs. 26.15 ± 0.96 ms, <i>p</i> = 0.027). When comparing diabetic patients without DR and with non-proliferative DR, we did not obtain statistically significant delays. Significant delays in the DA 0.01 “b”-wave (61.91 ± 5.52 ms vs. 66.36 ± 8.12 ms, <i>p</i> = 0.029), DA 3.0 “b”-wave (41.01 ± 2.50 ms vs. 44.16 ± 3.78 ms, <i>p</i> = 0.035), and LA 3.0 “a”-wave (16.21 ± 0.91 ms vs. 16.99 ± 1.16 ms, <i>p</i> = 0.045) were found between non-proliferative DR and pre-proliferative DR. When comparing the groups of patients with pre-proliferative DR and proliferative DR, the LA 3.0 ERG “b”-wave (32. 63 ± 2.53 ms vs. 36.19 ± 3.21 ms, <i>p</i> < 0.0001), LA 30 Hz flicker ERG “a”-wave (19.56 ± 3.59 vs. 21.75 ± 4.74 ms, <i>p</i>= 0.025), and “b”-wave (32.23 ± 4.02 vs. 36.68 ± 3.48 ms, <i>p</i> = 0.017) were delayed. Conclusions: the electrophysiological findings from our study indicate that there is a substantial dysfunction of the neural retina in all stages of DR.
first_indexed 2024-03-08T09:57:30Z
format Article
id doaj.art-1b2f23e01b9248a5b01d4070cf3ea929
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-08T09:57:30Z
publishDate 2023-12-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-1b2f23e01b9248a5b01d4070cf3ea9292024-01-29T13:46:43ZengMDPI AGBiomedicines2227-90592023-12-011214410.3390/biomedicines12010044Retinal Functional Impairment in Diabetic RetinopathyCornelia Andreea Tănasie0Alexandra Oltea Dan1Oana Maria Ică2Maria Filoftea Mercuț3George Mitroi4Citto-Iulian Taisescu5Veronica Sfredel6Ramona Ingrid Corbeanu7Carmen Luminița Mocanu8Ciprian Danielescu9Department of Physiology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, RomaniaDepartment of Physiology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, RomaniaDepartment of Dermatology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, RomaniaDepartment of Ophthalmology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, RomaniaDepartment of Urology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, RomaniaDepartment of Physiology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, RomaniaDepartment of Physiology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, RomaniaDepartment of Physiology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, RomaniaDepartment of Ophthalmology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, RomaniaDepartment of Ophthalmology, University of Medicine and Pharmacy “Grigore T. Popa”, 700111 Iasi, RomaniaBackground: Diabetic retinopathy (DR) is a neurodegenerative disease of the retina. The aim of our study was to analyze latency changes in a full-field electroretinogram (ERG) in patients with type 2 diabetes. Material: This prospective study included 15 diabetic patients without DR, 16 diabetic patients with non-proliferative DR, 14 patients with pre-proliferative DR, 15 patients with proliferative DR, and 14 age-matched controls. All the participants underwent ophthalmologic examination and full-field ERGs. The ERGs were recorded with the Metrovision MonPackOne system. The latencies were analyzed for “a”- and “b”-waves in the dark-adapted (DA) 0.01 ERG, DA 3.0 ERG, DA oscillatory potentials, light-adapted (LA) 3.0 ERG, and 30 Hz flicker ERG. Results: The delayed responses of healthy subjects compared to diabetic patients without DR were the DA oscillatory potentials (25.45 ± 1.04 ms vs. 26.15 ± 0.96 ms, <i>p</i> = 0.027). When comparing diabetic patients without DR and with non-proliferative DR, we did not obtain statistically significant delays. Significant delays in the DA 0.01 “b”-wave (61.91 ± 5.52 ms vs. 66.36 ± 8.12 ms, <i>p</i> = 0.029), DA 3.0 “b”-wave (41.01 ± 2.50 ms vs. 44.16 ± 3.78 ms, <i>p</i> = 0.035), and LA 3.0 “a”-wave (16.21 ± 0.91 ms vs. 16.99 ± 1.16 ms, <i>p</i> = 0.045) were found between non-proliferative DR and pre-proliferative DR. When comparing the groups of patients with pre-proliferative DR and proliferative DR, the LA 3.0 ERG “b”-wave (32. 63 ± 2.53 ms vs. 36.19 ± 3.21 ms, <i>p</i> < 0.0001), LA 30 Hz flicker ERG “a”-wave (19.56 ± 3.59 vs. 21.75 ± 4.74 ms, <i>p</i>= 0.025), and “b”-wave (32.23 ± 4.02 vs. 36.68 ± 3.48 ms, <i>p</i> = 0.017) were delayed. Conclusions: the electrophysiological findings from our study indicate that there is a substantial dysfunction of the neural retina in all stages of DR.https://www.mdpi.com/2227-9059/12/1/44full-field ERGdiabetes mellitusdiabetic retinopathy
spellingShingle Cornelia Andreea Tănasie
Alexandra Oltea Dan
Oana Maria Ică
Maria Filoftea Mercuț
George Mitroi
Citto-Iulian Taisescu
Veronica Sfredel
Ramona Ingrid Corbeanu
Carmen Luminița Mocanu
Ciprian Danielescu
Retinal Functional Impairment in Diabetic Retinopathy
Biomedicines
full-field ERG
diabetes mellitus
diabetic retinopathy
title Retinal Functional Impairment in Diabetic Retinopathy
title_full Retinal Functional Impairment in Diabetic Retinopathy
title_fullStr Retinal Functional Impairment in Diabetic Retinopathy
title_full_unstemmed Retinal Functional Impairment in Diabetic Retinopathy
title_short Retinal Functional Impairment in Diabetic Retinopathy
title_sort retinal functional impairment in diabetic retinopathy
topic full-field ERG
diabetes mellitus
diabetic retinopathy
url https://www.mdpi.com/2227-9059/12/1/44
work_keys_str_mv AT corneliaandreeatanasie retinalfunctionalimpairmentindiabeticretinopathy
AT alexandraolteadan retinalfunctionalimpairmentindiabeticretinopathy
AT oanamariaica retinalfunctionalimpairmentindiabeticretinopathy
AT mariafilofteamercut retinalfunctionalimpairmentindiabeticretinopathy
AT georgemitroi retinalfunctionalimpairmentindiabeticretinopathy
AT cittoiuliantaisescu retinalfunctionalimpairmentindiabeticretinopathy
AT veronicasfredel retinalfunctionalimpairmentindiabeticretinopathy
AT ramonaingridcorbeanu retinalfunctionalimpairmentindiabeticretinopathy
AT carmenluminitamocanu retinalfunctionalimpairmentindiabeticretinopathy
AT cipriandanielescu retinalfunctionalimpairmentindiabeticretinopathy